|
CA2788526A1
|
|
Extended release formulations of desvenlafaxine base
|
|
WO2011004298A1
|
|
Montelukast hexamethylenediamine salt and its use for the preparation of montelukast sodium
|
|
WO2011004281A1
|
|
A process for the preparation of amorphous form of rabeprazole sodium
|
|
WO2010092500A2
|
|
A process for the preparation of tolterodine tartrate
|
|
WO2010079405A2
|
|
An improved process for preparing 1-(pentanoylamino)cyclopentanecarboxylic acid
|
|
EP2391598A2
|
|
An improved process for the preparation of choline salt of fenofibric acid and its novel polymorph
|
|
EP2376471A2
|
|
An improved process for the preparation of duloxetine and salts thereof
|
|
CA2744468A1
|
|
An improved process for the preparation of 1-bromo-3,5-dimethyl adamantane
|
|
WO2010070510A2
|
|
A process for preparing quetiapine fumarate
|
|
CA2744451A1
|
|
A process for the preparation of donepezil hydrochloride
|
|
WO2010046808A2
|
|
A process for the preparation of venlafaxine hydrochloride
|
|
WO2010046804A2
|
|
A process for preparation of losartan potassium form i
|
|
WO2010046801A2
|
|
A process for the preparation of tolterodine tartrate
|
|
WO2010029457A2
|
|
An improved process for preparing losartan potassium
|
|
WO2010029458A2
|
|
A process for preparing quetiapine fumarate
|
|
EP2303835A1
|
|
A process for the preparation of teriflunomide
|
|
WO2010013157A2
|
|
Cost efficient process for preparation of sucralose
|
|
WO2009156938A2
|
|
A cost effective process for preparing 6,9-imino ether
|
|
WO2009147624A2
|
|
A process for preparing teriflunomide
|
|
WO2009147626A2
|
|
Anhydrous amorphous form of imatinib mesylate
|
